Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

SARMs Spells Latest 'Synthetic Steroids' FDA Finds In Supplements

Nov 01 2017

• By Malcolm Spicer

Related Content

SARMs Supplements Mean Recall To One Firm, False Advertising To Another

May 22 2017

Amarin's Omega-3 Fair Trade Complaint Reaches Regulatory Dead End

Oct 31 2017

Five Shanghai Suspects Charged After FDA Undercover Work On Spiked Supplements

Oct 26 2017

Recall DMAA Analog While FDA Evaluates Safety – CRN, Researchers

Oct 09 2014

Additional Topics

United States Dietary Supplements Ingredients FDA Regulation Safety Consumer

More from Ingredients & Safety

More from HBW Insight

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window